Searched for
DRUGMAKER PFIZER INC
Pfizer PFE stock, Metsera MTSR stock: Pfizer, Metsera share prices jump as deal worth over $7 billion gets thumbs upStock Market boom for both companies' shares came as Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up t...- Pfizer to maintain drug supply to Russia, stops new clinical trialsThe Russian invasion has left drugmakers scrambling to find ways for patients enrolled in clinical trials in Ukraine to receive their medic...
- Pfizer's COVID product sales to top $50 billion this year, investors want moreAlthough Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...
- Pfizer applies for COVID-19 vaccine approval in JapanDrugmaker Pfizer Inc said on Friday it had applied for approval in Japan for its COVID-19 vaccine, which is already being administered in t...
- Pfizer, BioNTech to co-develop potential coronavirus vaccineThe drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine's distribution outside China, th...
- Pfizer jumps 13% as parent co finds compounds with potential to treat Covid-19Drugmaker said that it identified certain antiviral compounds it had in development that have the potential to inhibit coronaviruses a
- Pfizer replaces longtime CEO Read with veteran BourlaRead, who was appointed CEO in December 2010, will become the executive chairman of Pfizer's board from Jan. 1.
- Pfizer acquires AstraZeneca's Neksium for Rs 75 croreNeksium was launched in India in the year 2006 and has developed strong equity with prescribers as a leading, high quality product in the A...
- Unichem Laboratories jumps on report of sale plansUnichem is exploring a sale of its domestic formulations business, and its proposal "is being studied" by private equity firms and strategi...
- Pfizer buying Hospira for about $15 billionThe deal is expected to add 10-12 cents per share to Pfizer's earnings in the first full-year after the deal closes.
- Pfizer to appeal India decision to revoke cancer drug patentPfizer Ltd, the India unit of US drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug...
- Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30Following a settlement in 2008, Pfizer Inc gave Ranbaxy exclusive marketing rights to sell Lipitor's low-cost version for six months.
- US court rejects Mylan plea against RanbaxyA US court has dismissed Mylan’s attempt to prevent Ranbaxy from launching a low-cost version of Lipitor in Nov, expected to bring $550-600...
- Orchid Chemicals settles case with Pfizer Inc; stock downHyderabad-based Orchid Chemicals has reached an out-of-court settlement with world’s largest drugmaker Pfizer Inc to sell a low-cost versio...
- Orchid Chemicals settles case with Pfizer IncOrchid Chemicals has reached an out-of-court settlement with world’s largest drugmaker Pfizer Inc to sell a low-cost version of the America...
- Pfizer awards bonuses to executives for Wyeth dealChief Financial Officer Frank D'Amelio will receive a $1.2 million award and Ian Read, group president of Pfizer's biopharmaceutical busine...
- Pfizer to tap bond market for $10.6 bnPfizer Inc, the world largest drugmaker, will raise $10.6 billion from its first sale of bonds in euros since 2007 and from a debut issue i...
- Reports: Pfizer, Wyeth said to be close to dealPfizer and Wyeth are closing in on a deal worth $68 billion that could be announced before the markets open Monday.
- Pfizer to spend 300 mn dlr on R&D in KoreaPfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...
- Pfizer to spend 300 mn dlr on R&D in KoreaPfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...
Load More
